The divestment by Oklo's leadership involves both direct and indirect holdings, as well as transactions related to family members. Mr. DeWitte's personal direct sales included 16,907 shares at a weighted average price of $69.06, with individual trade prices falling between $68.50 and $69.50. Additionally, he directly sold 43,093 shares at a weighted average price of $69.83, with transaction prices ranging from $69.51 to $70.05.
Indirectly, the filings show that 22,063 shares were sold through a Jacob DeWitte GRAT (Grantor Retained Annuity Trust) at a weighted average price of $70.42, with specific prices ranging from $70.34 to $70.51. A further 17,937 shares were sold via another Jacob DeWitte GRAT at a weighted average price of $70.61, with individual sales occurring between $70.52 and $70.68.
The filing also accounts for transactions involving Mr. DeWitte's spouse, Caroline Cochran. These included the sale of 60,000 shares held by Ms. Cochran at a weighted average price of $70.19, with prices between $70.05 and $70.34. Additionally, 40,000 shares were sold through a Caroline Cochran GRAT at a weighted average price of $70.95, with individual sales ranging from $70.68 to $71.38.
These leadership transactions occur just eight days before the company is scheduled to release its next earnings report on May 12. This timing coincides with broader strategic developments for Oklo Inc. The company recently announced a major collaboration involving NVIDIA and the Los Alamos National Laboratory. This initiative is designed to advance nuclear fuel validation and create essential nuclear infrastructure by combining Oklo’s advanced sodium-fast-reactor platform with NVIDIA’s AI infrastructure and the materials science expertise of Los Alamos. Following the announcement of this partnership, Oklo's stock experienced a 9% increase.
The analyst community has provided mixed but generally optimistic perspectives on the company's potential. Tigress Financial Partners initiated coverage with a buy rating and a price target of $130.00, pointing to the company's proprietary fuel cycle and reactor technologies. Similarly, HSBC started coverage with a buy rating and a price target of $96.00, noting Oklo's rapid progress in developing small modular reactors. These movements occur within a wider sector context where NuScale Power is also drawing attention due to geopolitical factors and the global shift toward clean energy solutions through nuclear technology.